Benzinga | Nov 3, 2020 07:05AM EST

Oxford Immunotec Global Q3 Sales $19.40M Beat $18.65M Estimate

Oxford Immunotec Global (NASDAQ:OXFD) reported quarterly sales of $19.40 million which beat the analyst consensus estimate of $18.65 million by 4.02 percent. This is a 8.57 percent decrease over sales of $21.22 million the same period last year.